SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000950123-10-011428
Filing Date
2010-02-11
Accepted
2010-02-11 13:51:34
Documents
2
Group Members
PROSPECT MANAGEMENT CO. III, L.L.C.PROSPECT VENTURE PARTNERS III, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A c95821sc13gza.htm SC 13G/A 50076
2 EXHIBIT 99.1 c95821exv99w1.htm EX-99.1 4056
  Complete submission text file 0000950123-10-011428.txt   56121
Mailing Address 435 TASSO ST SUITE 200 PALO ALTO CA 94301
Business Address 435 TASSO ST SUITE 200 PALO ALTO CA 94301 650-327-8800
Prospect Venture Partners III L P (Filed by) CIK: 0001311490 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A

Mailing Address 420 STEVENS AVENUE SUITE 210 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 210 SOLANA BEACH CA 92075 (858) 480-0400
Somaxon Pharmaceuticals, Inc. (Subject) CIK: 0001339455 (see all company filings)

IRS No.: 200161599 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-81290 | Film No.: 10590896
SIC: 2834 Pharmaceutical Preparations